
Chemical and Pharmaceutical Bulletin p. 1538 - 1544 (1998)
Update date:2022-08-05
Topics:
Kubota, Hirokazu
Kakefuda, Akio
Okamoto, Yoshinori
Fujii, Masahiro
Yamamoto, Osamu
Yamagiwa, Yoko
Orita, Masaya
Ikeda, Ken
Takeuchi, Makoto
Shibanuma, Tadao
Isomura, Yasuo
To discover a novel NK1-NK2 dual antagonist, we have synthesized a series of spiro-substituted piperidines utilizing YM-35375 as a lead compound, and evaluated affinities for NK1 and NK2 receptors. In the N- met
View MoreChemsky(shanghai)International Co.,Ltd.
Contact:0
Address:0
Sinoway International (Jiangsu) Co., Ltd.
Contact:+86-25-86630167
Address:17 Beijing Road (West), Nanjing, China
Contact:+86-158-05817090
Address:ROOM 9F, FLAT 2, GUODU DEVELOPING BLDG, No.182, ZHAOHUI ROAD
website:http://www.hope-chem.com
Contact:86-21-58090396-805
Address:Floor 4, Building 5, No.588 Tianxiong Road, Zhoupu International Medical Zone, ShangHai, China
Contact:+86-20-32051076
Address:1105,Building A, International Business Incubator,Science City
Doi:10.1002/ejoc.201901894
(2020)Doi:10.1021/jo9808526
(1998)Doi:10.1021/jm050879z
(2006)Doi:10.1002/adsc.201801137
(2019)Doi:10.1016/j.molcatb.2013.08.013
(2013)Doi:10.1016/j.ica.2021.120590
(2021)